Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rani Therapeutics Holdings (RANI) Interest Coverage Ratio (2020 - 2025)

Rani Therapeutics Holdings has reported Interest Coverage Ratio over the past 6 years, most recently at 24.6 for Q4 2025.

  • Quarterly results put Interest Coverage Ratio at 24.6 for Q4 2025, down 84.83% from a year ago — trailing twelve months through Dec 2025 was 13.25 (down 25.0% YoY), and the annual figure for FY2025 was 13.25, down 25.1%.
  • Interest Coverage Ratio for Q4 2025 was 24.6 at Rani Therapeutics Holdings, down from 10.01 in the prior quarter.
  • Over the last five years, Interest Coverage Ratio for RANI hit a ceiling of 13362.0 in Q4 2021 and a floor of 252.55 in Q3 2021.
  • Median Interest Coverage Ratio over the past 5 years was 13.44 (2023), compared with a mean of 712.54.
  • Peak annual rise in Interest Coverage Ratio hit 15775.49% in 2021, while the deepest fall reached 471.75% in 2021.
  • Rani Therapeutics Holdings' Interest Coverage Ratio stood at 13362.0 in 2021, then crashed by 100.18% to 24.31 in 2022, then surged by 57.37% to 10.37 in 2023, then dropped by 28.38% to 13.31 in 2024, then tumbled by 84.83% to 24.6 in 2025.
  • The last three reported values for Interest Coverage Ratio were 24.6 (Q4 2025), 10.01 (Q3 2025), and 11.98 (Q2 2025) per Business Quant data.